Cargando…

Long Chain N3-PUFA Decreases ACE2 Protein Levels and Prevents SARS-CoV-2 Cell Entry

Angiotensin-converting enzyme 2 (ACE2) is a target of interest for both COVID-19 and cardiovascular disease management. Even though lower ACE2 levels may be beneficial in SARS-CoV-2 infectivity, maintaining the ACE1/ACE2 balance is also crucial for cardiovascular health. So far, reports describing c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shiqi, Taylor, Carla G., Zahradka, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695276/ https://www.ncbi.nlm.nih.gov/pubmed/36430303 http://dx.doi.org/10.3390/ijms232213825

Ejemplares similares

The Potential of Docosahexaenoic Acid (DHA) in SARS-CoV-2 Management: DHA Reduces ACE2 Levels in Endothelial Cells
por: Huang, Shiqi, et al.
Publicado: (2021)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
por: He, Ming-Feng, et al.
Publicado: (2022)

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
por: Qiao, Yuanyuan, et al.
Publicado: (2021)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
por: Han, Dong P., et al.
Publicado: (2006)

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
por: Zamorano Cuervo, Natalia, et al.
Publicado: (2020)

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020)

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
por: Wang, Qihui, et al.
Publicado: (2020)

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
por: Ahmad, Iqrar, et al.
Publicado: (2021)

TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2
por: Wang, Yinfang, et al.
Publicado: (2021)

Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
por: D’Onofrio, Nunzia, et al.
Publicado: (2021)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
por: Karthika, Thankamani, et al.
Publicado: (2021)

“Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry
por: Shukla, Satya Prakash, et al.
Publicado: (2021)

Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor
por: Fonnesu, Rossella, et al.
Publicado: (2022)

Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry
por: Yoshizato, Katsutoshi, et al.
Publicado: (2022)

Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract
por: Liu, Yichuan, et al.
Publicado: (2020)

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
por: Burgueño, Juan F, et al.
Publicado: (2020)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Site-Specific Fat-1 Knock-In Enables Significant Decrease of n-6PUFAs/n-3PUFAs Ratio in Pigs
por: Li, Mengjing, et al.
Publicado: (2018)

Long-chain n-3 PUFA in vegetarian women: a metabolic perspective
por: Burdge, Graham C., et al.
Publicado: (2017)

Prime editor‐mediated functional reshaping of ACE2 prevents the entry of multiple human coronaviruses, including SARS‐CoV‐2 variants
por: Zhao, Wenwen, et al.
Publicado: (2023)

Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
por: Lim, Key-Hwan, et al.
Publicado: (2020)

Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota
por: Edwinson, Adam, et al.
Publicado: (2021)

Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
por: Liu, Jiamnin, et al.
Publicado: (2022)

Effect of polymorphism in Rhinolophus affinis ACE2 on entry of SARS-CoV-2 related bat coronaviruses
por: Li, Pei, et al.
Publicado: (2023)

Integrin αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2
por: Cai, Zeqiong, et al.
Publicado: (2023)

Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva
por: Mencucci, Rita, et al.
Publicado: (2021)

Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium
por: Jacobs, Merel, et al.
Publicado: (2021)

Decreased interfacial dynamics caused by the N501Y mutation in the SARS-Cov-2 s1 spike:ACE2 complex
por: Ahmed, Wesam S., et al.
Publicado: (2022)

Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice
por: Su, Ping, et al.
Publicado: (2022)

ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
por: Scagnolari, Carolina, et al.
Publicado: (2021)

Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry
por: Ren, Wenlin, et al.
Publicado: (2021)

Predicting the Ability of SARS-CoV-2 to Utilize the ACE2 Receptor for Cell Entry in North American Rodents
por: Lund-Andersen, Peik K., et al.
Publicado: (2021)

APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
por: Zhang, Hongsheng, et al.
Publicado: (2022)

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
por: Baggen, Jim, et al.
Publicado: (2023)

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation
por: Bezzerri, Valentino, et al.
Publicado: (2023)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1415uoa7tdvlu75spd9f7gg9k1